We are live on ! Find out more
APEN

Apollo Endosurgery, Inc.

Delisted

APEN was delisted on the 3rd of April, 2023.

81 hedge funds and large institutions have $368M invested in Apollo Endosurgery, Inc. in 2022 Q4 according to their latest regulatory filings, with 40 funds opening new positions, 19 increasing their positions, 14 reducing their positions, and 11 closing their positions.

New
Increased
Maintained
Reduced
Closed

82,200% more call options, than puts

Call options by funds: $33.7M | Put options by funds: $41K

264% more first-time investments, than exits

New positions opened: 40 | Existing positions closed: 11

111% more capital invested

Capital invested by funds: $174M → $368M (+$194M)

60% more funds holding in top 10

Funds holding in top 10: 58 (+3)

53% more funds holding

Funds holding: 5381 (+28)

36% more repeat investments, than reductions

Existing positions increased: 19 | Existing positions reduced: 14

Holders
81
Holders Change
+28
Holders Change %
+52.83%
% of All Funds
1.3%
Holding in Top 10
8
Holding in Top 10 Change
+3
Holding in Top 10 Change %
+60%
% of All Funds
0.13%
New
40
Increased
19
Reduced
14
Closed
11
Calls
$33.7M
Puts
$41K
Net Calls
+$33.7M
Net Calls Change
+$22.3M
Name Holding Trade Value Shares
Change
Change in
Stake
Qube Research & Technologies (QRT)
26
Qube Research & Technologies (QRT)
United Kingdom
$2.85M +$2.13M +286,040 New
GF
27
Gabelli Funds
New York
$2.76M +$2.07M +277,274 New
BHMP
28
Bardin Hill Management Partners
New York
$2.57M +$1.92M +257,312 New
Renaissance Technologies
29
Renaissance Technologies
New York
$2.09M +$852K +114,300 +120%
TAL
30
TIG Advisors LLC
New York
$1.96M +$1.47M +196,665 New
Northern Trust
31
Northern Trust
Illinois
$1.96M +$26.7K +3,585 +2%
GCIA
32
Gabelli & Co Investment Advisers
New York
$1.91M +$1.43M +191,850 New
BCM
33
Bridgeway Capital Management
Texas
$1.75M
ACA
34
Apis Capital Advisors
New York
$1.69M +$224K +30,000 +21%
MAM
35
Miria Asset Management
Malta
$1.65M +$1.24M +165,691 New
GCL
36
Glazer Capital LLC
New York
$1.63M +$1.22M +162,947 New
Susquehanna International Group
37
Susquehanna International Group
Pennsylvania
$1.62M +$1.21M +162,525 New
Goldman Sachs
38
Goldman Sachs
New York
$1.49M -$5.57M -746,980 -83%
BCM
39
BCK Capital Management
Connecticut
$1.39M +$1.04M +139,000 New
Boston Partners
40
Boston Partners
Massachusetts
$1.36M -$240K -32,210 -19%
NSEDCP
41
NJ State Employees Deferred Compensation Plan
New Jersey
$1.3M
State Street
42
State Street
Massachusetts
$1.18M +$213K +28,600 +32%
HF
43
HRT Financial
New York
$803K +$601K +80,598 New
WVP
44
Worth Venture Partners
New Jersey
$775K -$364K -48,839 -39%
Bank of New York Mellon
45
Bank of New York Mellon
New York
$558K +$56.6K +7,594 +16%
CL
46
CSS LLC
Illinois
$501K +$374K +50,215 New
Neuberger Berman Group
47
Neuberger Berman Group
New York
$499K
HM
48
Harvest Management
New York
$499K +$373K +50,000 New
TI
49
Trexquant Investment
Connecticut
$488K +$365K +48,973 New
GI
50
GAMCO Investors
Connecticut
$439K +$328K +44,007 New

APEN Hedge Fund Activity: Q4 2022 in Review

81 of the 6,221 institutional investors tracked by Wall St. Rank reported a position in Apollo Endosurgery, Inc. (APEN) for Q4 2022, worth a combined $368M — up 111% from $174M a quarter earlier.

Buyers outnumbered sellers: 40 funds opened new APEN positions and 11 closed out — a net gain of 29 holders — while 19 added to existing stakes and 14 trimmed.

The largest buyer was CPMG Inc, adding an estimated $16.6M. The largest seller was Soleus Capital Management, exiting entirely with an estimated $6.26M sold.

  • 81 institutional investors held Apollo Endosurgery, Inc. (APEN) as of Q4 2022, up from 53 in Q3 2022.
  • Funds reported $368M of Apollo Endosurgery, Inc. stock for Q4 2022, up 111% quarter-over-quarter.
  • 40 funds opened new Apollo Endosurgery, Inc. positions in Q4 2022 and 11 closed out, a net change of +29 holders.
  • The largest Apollo Endosurgery, Inc. buyer in Q4 2022 was CPMG Inc, an estimated $16.6M added.
  • The largest Apollo Endosurgery, Inc. seller in Q4 2022 was Soleus Capital Management, an estimated $6.26M sold.

Based on aggregated 13F filings for Q4 2022.